Eczema care online
- Conditions
- Dermatitis and eczemaSkin and Connective Tissue Diseases
- Registration Number
- ISRCTN79282252
- Lead Sponsor
- niversity of Southampton
- Brief Summary
2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33550268/ protocol (added 09/02/2021) 2022 Results article in https://doi.org/10.1136/bmj-2022-072007 (added 13/12/2022) 2024 Results article in https://pubmed.ncbi.nlm.nih.gov/38194207/ within-trial economic evaluation results (added 10/01/2024)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 677
Trial-YP:
1. Young person aged 13-25 years with eczema
2. Identified from GP records as having eczema and have obtained a prescription for eczema treatment in the past 12 months
3. POEM score greater than 5 to include mild to severe eczema, but exclude those with very mild eczema to avoid floor effects
4. Internet access
Trial-PC:
1. Parent / carer of a child aged 0-12 years with eczema
2. Child was identified from GP records as having eczema and has obtained a relevant prescription in the past 12 months
3. Child has a POEM score greater than 5 to include mild to severe eczema, but exclude those with very mild eczema
4. Have internet access
Only 1 person per household will be able to take part in each trial. If a parent / carer in trial-PC has more than one child who meets the inclusion criteria they will be asked to specify one child to participate in the trial.
1. Unable to give informed consent
2. Unable to read and write English as the intervention content and outcome measures are in English
3. Taken part in another eczema intervention in the past 3 months.
4. Took part in think-aloud interviews as part of ECO intervention development. (Qualitative interviewees who did not view intervention materials will NOT be excluded)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method